MétaCan
Menu
Retour à la cohorte
Enregistrement W3109347217 · doi:10.1016/j.eclinm.2020.100633

Applying the lessons of COVID-19 response to Canada's worsening opioid epidemic

2020· article· en· W3109347217 sur OpenAlexaffabout
A. Norton, Thomas Kerr

Notice bibliographique

RevueEClinicalMedicine · 2020
Typearticle
Langueen
DomaineMedicine
ThématiqueInfluenza Virus Research Studies
Établissements canadiensUniversity of British ColumbiaSt. Paul's Hospital
Organismes subventionnairesnon disponible
Mots-clésPublic healthPandemicMedicinePreparednessCoronavirus disease 2019 (COVID-19)Environmental healthDiseaseInfectious disease (medical specialty)Political scienceNursing

Résumé

récupéré en direct d'OpenAlex

Global pandemics, such as coronavirus disease 2019 (COVID-19), often reveal glaring deficiencies within our public health systems. However, such major public health threats also present opportunities to strengthen existing public health structures and responses. Past communicable disease pandemics, such as severe acute respiratory syndrome (SARS) in 2003 and H1N1 influenza in 2009, exposed systemic weaknesses in the ability of global health systems to respond to novel pathogens, but led to new protocols and improved infrastructure [[1]Fineberg J. Pandemic preparedness and response – lessons from the H1N1 influenza of 2009.N Engl J Med. 2015; 372: 197https://doi.org/10.1056/nejmx140045Crossref Google Scholar,[2]Health CanadaLearning from SARS: renewal of public health in Canada. Health Canada, Ottawa, ON2003: 234https://www.phac-aspc.gc.ca/publicat/sars-sras/pdf/sars-e.pdfGoogle Scholar]. The current COVID-19 pandemic, while associated with significant morbidity and mortality, has created yet another opportunity for reflection: specifically, on the equity of pandemic response. The current situation in Canada, where the co-occurring epidemics of COVID-19 and opioid-related overdose persist, presents a useful case example of such inequities. The Canadian COVID-19 response has been lauded at home and internationally for its early success in flattening the COVID-19 “curve.” At the same time, the opioid response is receiving increasing criticism from public health experts [[3]Tyndall M. Safer opioid distribution in response to the COVID-19 pandemic.Int J Drug Policy. 2020; (Forthcoming – 2020)https://doi.org/10.1016/j.drugpo.2020.102880Crossref PubMed Scopus (70) Google Scholar]. In the province of British Columbia (BC), the epicentre of the opioid epidemic and where an opioid overdose public health emergency was declared in 2016, more than 5800 lives have been claimed, largely due to the presence of fentanyl and other synthetic opioid analogues in the illicit drug supply, which are highly potent and can easily lead to overdose [[4]British Columbia Coroner's ServiceIllicit drug toxicity deaths in BC: January 1, 2010 – August 31. Minister of Public Safety and Solicitor General, Burnaby, BC2020: 24https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdfGoogle Scholar]. In March 2020, COVID-19 became BC's second-ever public health emergency (after the opioid overdose public health emergency), resulting in a number of measures that exacerbated the opioid epidemic. For example, the Canadian–US border closure disrupted drug supply chains, increasing drug toxicity and extreme fentanyl concentrations [[4]British Columbia Coroner's ServiceIllicit drug toxicity deaths in BC: January 1, 2010 – August 31. Minister of Public Safety and Solicitor General, Burnaby, BC2020: 24https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdfGoogle Scholar]. Social distancing and self-isolation measures, in combination with reduced access to services such as supervised consumption facilities, health care and other harm reduction services, have increased the risk of withdrawal, treatment interruptions, overdose, and mortality [[5]Perri M. Dosani N. Hwang S.W COVID-19 and people experiencing homelessness: challenges and mitigation strategies.CMAJ. 2020; 192: e716-3719https://doi.org/10.1503/cmaj.200834Crossref PubMed Scopus (124) Google Scholar]. In June, BC recorded its worst number of opioid-related deaths ever: 183, up from 76 in June of 2019 [[4]British Columbia Coroner's ServiceIllicit drug toxicity deaths in BC: January 1, 2010 – August 31. Minister of Public Safety and Solicitor General, Burnaby, BC2020: 24https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdfGoogle Scholar]. On June 26, 2020, paramedics in the province responded to 131 overdose calls, the highest recorded in a single day [[6]Britten L.B.C. paramedics responded to 131 overdoses on June 26, ‘the most recorded in a single day.’ CBC News, 2020. Available from: https://www.cbc.ca/news/canada/british-columbia/bc-overdose-record-1.5631898Google Scholar]. Many people have died alone in their own homes, isolated in part because of social distancing measures. The number of opioid-related deaths this summer alone has far exceeded the total of 284 deaths in BC due to COVID-19 [[7]BC Centre for Disease Control. COVID-19 dashboard. Available from: http://www.bccdc.ca/health-info/diseases-conditions/covid-19/dataGoogle Scholar]. Canada has a long history of responding to pandemics. In 1918, the arrival of the Spanish Flu was met with confusion over authority, jurisdiction, and information sharing, resulting in an ad hoc response but contributing in large part to the creation of the Department of Health. With the SARS outbreak in 2003, Canada was again challenged with a lack of coordination across institutions and jurisdictions, as well as systemic deficiencies in clinical and health care settings, epidemiologic investigation, and outbreak management and emergency protocols. The SARS outbreak, and the recommendations that stemmed from it, helped inform the structure of the current public health system, including the creation of the Public Health Agency of Canada, now leading the COVID-19 response. The current COVID-19 and opioid-related overdose public health crises afflicting Canada and BC have revealed two things: that Canada has learned from past pandemics and created robust public health infrastructure in response, and that the full force of Canadian public health intervention is not equitably deployed. What COVID-19 has demonstrated is that science, policy, and data can be rapidly mobilized. On March 23, 2020, 12 days after the World Health Organization declared COVID-19 a global pandemic, the federal government announced $275 million in funding for coronavirus research and medical countermeasures [[8]Trudeau J. Canada's plan to mobilize science to fight COVID-19. 2020. Available from: https://pm.gc.ca/en/news/news-releases/2020/03/23/canadas-plan-mobilize-science-fight-covid-19Google Scholar]. Seventy-one clinical trials for drugs and vaccines have since been authorized [[9]Government of Canada. Drugs and vaccines for COVID-19: list of authorized clinical trials. 2020. Available at: https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-clinical-trials/list-authorized-trials.htmlGoogle Scholar]. Epidemiological data is released daily. Canada has not witnessed the same action on the opioid crisis. Up-to-date epidemiological data at the national level is not available. Harm reduction—an approach that reduces the harms associated with substance use—remains under ideological assail, even during COVID-19. For example, in August 2020, in the province of Alberta, the United Conservative Party-led government closed North America's busiest safe consumption site (SCS) in the face of significant research and evidence demonstrating that SCSs save lives and reduce drug-related harms, opting to instead focus on abstinence-based approaches [[10]Kamran H. Fleming T. The shameful closure of North America's busiest safe consumption site.Filter Mag. 2020; (Available from)https://filtermag.org/closure-safe-consumption-site/Google Scholar]. Government investments in research and clinical trials for opioid use disorder remain limited. Two policy interventions that would have an immediate impact and save lives, but have not been broadly implemented, are the decriminalization of personal use of drugs and the provision of a “safe supply” of legal and regulated pharmaceutical-grade drugs.3 These policy interventions are supported by high-ranking health officials, including BC's Provincial Health Officer and Chief Coroner, but continue to face legal and regulatory barriers that prevent them from being widely available. A more significant barrier has been politicians and decision-makers, who are reticent to implement these policies despite mounting death tolls. COVID-19 has highlighted the Canadian public health system's strengths. It has also created opportunities for learning. Officials are realizing that pandemic response can have unintended consequences of immense scale. With every passing month, it becomes clearer that the full force of Canadian public health intervention is not equitably deployed. The time has come to set the balance right and leverage learnings from the present and past pandemics to adequately respond to the opioid overdose epidemic. The authors have nothing to disclose.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,004
score de la tête « metaresearch » (Gemma)0,110
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMétarecherche
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Commentaire · Signal consensuel: aucune
Score de désaccord entre enseignants0,633
Score d'incertitude au seuil0,968

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0040,110
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,000
Bibliométrie0,0000,001
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,001
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,284
Tête enseignante GPT0,490
Écart entre enseignants0,206 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations26
Publié2020
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueEClinicalMedicineMême sujetInfluenza Virus Research StudiesTravaux en français237 207